Opportunity for catch-up HPV vaccination in young women after first delivery

J Epidemiol Community Health. 2010 Jul;64(7):610-5. doi: 10.1136/jech.2008.086439. Epub 2009 Aug 19.

Abstract

Background: Early age at first delivery has been identified as a risk factor for high-risk HPV-type infection and cervical cancer development.

Methods: A cross-sectional study was carried out in a large public maternity hospital in São Paulo, Brazil. During June 2006 to February 2007, 301 women aged 15-24 years who gave birth to their first child were recruited between 43 and 60 days after delivery. Detection of HPV DNA in cervical specimens was performed using a standardised PCR protocol with PGMY09/11 primers. The association of selected factors with HPV infection was assessed by using a Generalised Linear Model.

Results: HPV DNA was detected in 58.5% (95% CI 52.7% to 64.0%) of the enrolled young women. The most common types of HPV found were: HPV16, HPV51, HPV52, HPV58 and HPV71. The overall prevalence of HPV types targeted by the HPV prophylactic vaccines was: HPV 16-12.0%, HPV 18- 2.3% and HPV 6 and 11 4.3%. In the multivariate analysis, only age (inversely, p for trend=0.02) and smoking habits were independently associated with HPV infection.

Conclusions: The findings show that these young primiparous women had high cervical HPV prevalence, suggesting that this is a high-risk group for cervical cancer development. Nevertheless, 17.3% were positive for any of the four HPV types included in HPV vaccines (HPV6, 11, 16 or 18), with 13.3% positive for HPV 16 or 18 and only 1.0% having both vaccine related-oncogenic HPV types. Thus, young primiparous women could benefit from catch-up HPV vaccination programmes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Alphapapillomavirus / genetics
  • Brazil
  • Cross-Sectional Studies
  • DNA, Viral / genetics
  • Female
  • Humans
  • Maternal Age
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Infections / virology
  • Papillomavirus Vaccines / administration & dosage*
  • Parity*
  • Postpartum Period*
  • Poverty
  • Pregnancy
  • Prevalence
  • Risk Factors
  • Time Factors
  • Vaginal Smears
  • Young Adult

Substances

  • DNA, Viral
  • Papillomavirus Vaccines